Summary
CMS finalized its CY 2027 home health rule on November 4, lifting aggregate Medicare payments to home health agencies by an estimated 2.4% (about $415 million) while keeping a 3.0% temporary cut and widening its power to revoke Medicare enrollment retroactively.
Providers welcomed the raise, worried about enforcement, and said neither fixes labor costs. This guide covers what changed, who said what, and how the rule lands in home health, hospice, palliative care, home care, hospitals, suppliers, health plans and patients’ homes.
Introduction
Medicare is paying home health agencies more and watching them harder, all inside one rule. That pairing will decide which agencies keep admitting medically complex patients in 2027, how fast hospital teams can find a place at home for someone ready to leave, and whether physicians feel safe ordering skilled palliative care for people with serious illness.
The final CY 2027 Home Health Prospective Payment System rule, CMS-1844-F, went on display at the Federal Register on November 4 and was published on November 9 (91 FR 72022). It follows a July proposal that surprised the industry by offering a raise after years of proposed cuts. The final version keeps that raise nearly intact. It also keeps the 3% temporary reduction and adds enrollment powers that reach far beyond home health.
Here’s the full picture: the provisions, the reactions from every quarter, the impact by care setting, and the questions people keep asking.
What did CMS finalize in the CY 2027 home health rule?
CMS finalized a 2.4% aggregate payment increase for home health agencies (about $415 million), a continued 3.0% temporary reduction, retroactive Medicare enrollment revocation across all revocation grounds, a 45-day OASIS submission deadline, and a clarification that skilled palliative care fits inside the existing home health benefit.
The numbers below come from the CMS fact sheet for the final rule. The home health payment update is 2.1%, worth $365 million. An updated fixed dollar loss amount adds an estimated 0.3%, worth $50 million. Together they produce the 2.4% aggregate figure, slightly under the $420 million CMS estimated in July.
| Provision | What CMS finalized | Who feels it most |
| Aggregate payment | About +2.4% ($415 million) versus CY 2026: a 2.1% update plus 0.3% from the outlier threshold | Home health agencies |
| Temporary adjustment | -3.0% to the 30-day base rate, continuing recoupment for CY 2020 to 2025 | Agency finance teams |
| Permanent adjustment | None added for 2027; CMS keeps analyzing CY 2026 claims | Agencies planning for 2028 |
| Case-mix and LUPA | Weights recalibrated across 432 PDGM groups on CY 2025 data; LUPA thresholds, functional levels and comorbidity subgroups updated; final 30-day base rate $2,092.69 | Clinical, coding and scheduling teams |
| Retroactive revocation | Every Medicare enrollment revocation ground takes effect as of the date noncompliance began | All Medicare providers and suppliers |
| New revocation grounds | Certain misdemeanor convictions, excessive provider concentration in a limited area, and suspensions tied to owners and managing employees | All Medicare providers and suppliers |
| Ownership changes | Home health agencies, hospices and DMEPOS suppliers re-enroll as new providers and undergo a survey or accreditation after certain majority ownership changes | Owners, buyers and investors |
| OASIS deadline | Submission window shortens from 135 days to 45 days | Quality and clinical operations |
| Palliative care | Skilled palliative care confirmed within the existing home health benefit; examples to follow in guidance | Physicians, agencies and hospices |
| Home infusion DME | External infusion pumps and associated drugs join the DME benefit on April 1, 2027 | Infusion suppliers and patients |
| Wage index | Comments on a home health-specific wage index summarized; no methodology or timeline announced | Agencies in low-wage-index areas |
Payment: a raise after years of cuts
The direction matters as much as the size. CMS proposed an aggregate cut of 6.4% for CY 2026 and 1.7% for CY 2025, according to Home Health Care News, and the CY 2026 final rule still trimmed payments by 1.3%, or $220 million, by CMS’s estimate. A 2.4% increase reverses the pattern. Providers now have a baseline they can plan around, which is the first thing most leaders mention when asked about the rule.
Outlier payments, which cover periods of unusually high cost, stay capped at 2.5% of total payments, and the final fixed dollar loss ratio is 0.29%.
The 3% temporary adjustment is still in place
CMS finalized another 3.0% temporary reduction to the 2027 national standardized payment rate. The agency says it is recouping retrospective overpayments for calendar years 2020 through 2025, and it believes spreading the recovery may avoid a much larger cut later. The final rule puts the total at about $4.9 billion through CY 2025 and estimates that the 3% reduction will recoup about $500 million of it. The National Alliance for Care at Home has warned that a 3% annual pace would run roughly ten years.
No new permanent adjustment was added for 2027. CMS says it will keep studying CY 2026 claims, as the statute requires, so the permanent-adjustment question can return in next year’s rule. Our breakdown of the proposed rate math and margin sensitivity shows how a 3% reduction interacts with cost growth. The final 30-day base rate is $2,092.69 after the temporary adjustment, per the final rule.
Program integrity: the quieter headline
The enrollment provisions may matter more to many readers than the payment line. CMS says the changes will save about $82 million a year by letting the agency recover payments from noncompliant providers and keep high-risk applicants out of Medicare. Administrator Dr. Mehmet Oz described the goal as holding noncompliant providers accountable while protecting seniors, taxpayer dollars and access to care. CMS also says the new authorities are targeted and that it will weigh the facts of each case.
- Retroactive revocation. Every revocation ground now takes effect as of the date noncompliance began, so CMS can recover payments back to that date. Before, some revocations applied only 30 days after notice. The final rule also cuts the window for a revoked provider to submit outstanding claims from 60 days to 15 days, counted from the date of the revocation letter.
- New and expanded grounds. These include certain misdemeanor convictions tied to sexual assault or financial misconduct, and enrollments CMS judges high risk because of an excessive concentration of providers in a limited geographic area.
- Ownership changes. Home health agencies, hospices and DMEPOS suppliers must re-enroll as new providers and pass a survey or accreditation after certain changes in majority ownership. CMS can deny or revoke enrollment if they skip the step.
- Owners and managing employees. Existing license and program suspension grounds now reach a provider’s owners and managing employees or organizations. The final rule defines managing employees as anyone who exercises operational or managerial control over day-to-day operations, and it names medical directors, clinical directors, departmental heads, supervising physicians, nursing directors and alternate administrators.
- Affiliations. The final rule removes the five-year affiliation lookback.
- Stricter requirements for hospices and home health agencies on administrator qualifications, alongside the ownership rules.
Context sharpens the picture. On November 12, CMS extended the national enrollment moratorium on new home health agencies and hospices by six months, and the extension lets currently enrolled agencies add new practice locations. Home Health Care News also notes that these provisions arrive next to the CRUSH fraud initiative, so scrutiny stacks.
Quality reporting and the 45-day OASIS clock
CMS cut the OASIS data submission deadline from 135 days to 45 days, which moves public reporting of home health quality up by as much as three months. About 98% of agencies already submit within 45 days, so the change formalizes what most do today. Reporting for the annual payment update will cover a full calendar year of data, and CMS tightened the digital hand-off during compliance reconsideration. It also gathered input on advance care planning as a possible future measure and made no model-specific changes to expanded HHVBP. Agencies still finishing their data groundwork should read our data foundation playbook for 2027, which covers how CMS intends to count OASIS assessments from every payer for start-of-care dates on or after January 1, 2027.
Palliative care: the existing benefit, spelled out
CMS confirms that eligible patients with serious illness can receive skilled palliative care, including pain and symptom management, under the home health benefit. The rule creates no new benefit. Eligibility depends on a patient’s care needs and Medicare’s home health criteria, and no specific diagnosis is required. Palliative care under this benefit is separate from hospice. CMS says it will publish examples of skilled palliative services through sub-regulatory guidance after the final rule posts, and it hasn’t given a date.
Home infusion, DMEPOS and the wage index
- Infusion coverage. External infusion pumps and associated home infusion drugs join the DME benefit on April 1, 2027. The FDA labeling must call for administration by or under supervision of a healthcare professional, a qualified home infusion therapy supplier must handle it in the home, and the drug must be infused at least 12 times a year. CMS swapped its proposed once-a-month test for the 12-times-a-year standard and placed no restriction on who counts as a healthcare professional.
- Replacement items. An identical DMEPOS replacement item needs no repeat face-to-face visit, though suppliers must produce the original encounter documentation if audited.
- Competitive bidding. The Form C reporting form gains a country-of-origin field for lead items, which will appear in the Medicare Supplier Directory.
- Wage index. CMS summarized comments on building a home health-specific wage index from an alternate source such as the Bureau of Labor Statistics. It announced no methodology or timeline.
Proposed rule versus final rule at a glance
| Item | July 1 proposal | November 4 final rule |
| Aggregate payment change | +2.4% (about $420 million) | +2.4% (about $415 million) |
| Payment update | 2.1% (about $370 million) | 2.1% ($365 million) |
| Outlier threshold effect | +0.3% ($50 million) | +0.3% ($50 million); fixed dollar loss ratio 0.29% |
| Temporary adjustment | -3.0% | -3.0% |
| New permanent adjustment | None | None |
| Revocation timing | Retroactive revocation proposed | Retroactive to the date noncompliance began, for all grounds |
| Home infusion frequency test | Once per month | At least 12 times per year |
| OASIS submission | Shorter deadline proposed | 45 days, down from 135 |
| Wage index | Request for information | Comments summarized; no plan announced |
| Palliative care | Discussion and request for comment | Response to comments; examples promised in later guidance |
| Claims window after revocation | Proposed cutting the window to submit outstanding claims from 60 days to 15 | 15 days from the date of the revocation letter |
| Managing employee definition | Proposed expanding it to name clinical roles such as clinical directors and nursing directors | Finalized without modification |
| Five-year affiliation lookback | Proposed removing it | Removed |
How did the healthcare industry react to the 2027 home health final rule?
Relief on the rate, concern about enforcement, and frustration that a 2.4% increase still trails labor costs. Providers and trade groups mostly back going after bad actors. They split on whether compliant agencies will get swept up with them.
Home Health Care News collected provider reactions the day after release, and the pattern was consistent. Leaders were glad for a raise and then moved quickly to what the rule leaves out: staffing costs, the temporary adjustment, and the risk of a paperwork error turning into a retroactive revocation.
Providers
| Voice | Reaction |
| Bayada Home Health Care (Bryony Winn, CEO) | Relieved. The raise supports clinicians and gives dependable funding to onboard new talent, though the rule adds time demands and resource needs. |
| LiveWell Partners (Stacie Bratcher, CEO) | Says the rule favors agencies that invested in documentation and oversight, and that compliance infrastructure is now a core operating cost. Notes 2.4% trails recruiting and retention costs and wants continued pressure on the temporary adjustment and Medicare Advantage rates. |
| VNS Health (Dan Savitt, President and CEO) | Points out that cumulative Medicare home health updates total 5.8% since 2020, against 20% or more for hospitals and skilled nursing facilities, and says the gap hurts hiring and capacity. |
| HealthView Home Healthcare Services (Steven Gonzalez, CEO) | Backs going after bad actors but wants precision, citing this year’s Los Angeles County crackdown. Worries that siloed CMS contractors make good agencies answer the same questions repeatedly. Most encouraged by the palliative care clarification. |
| Cornerstone VNA (Jennifer Ufkin, President and CEO) | Commenting on the proposal, supported a home health-specific wage index and said costs are rising three to five times faster than reimbursement. |
Trade groups and advocacy organizations
| Organization | Position |
| National Alliance for Care at Home | Called the increase the biggest update in nearly two decades outside 2022 and welcomed the stability. Still objects to the 3% adjustment as detached from true cost and built on data tainted by bad actors. Says CMS withdrew or narrowed several enrollment proposals, yet warns that broad disclosure provisions can catch legitimate providers over third-party conduct, shared buildings, vendor relationships or administrative errors. Also warns that clinical leadership titles are presumptively reportable managing employees, and that a late disclosure can support a retroactive revocation. |
| LeadingAge | Called the final rule out of touch with provider realities in a November 5 statement. Said the 2.4% increase beats recent cuts but leaves financial pressure unaddressed, and objected to the 3% temporary reduction. Welcomed the absence of revocation grounds tied to the Medicare debt and payment suspensions of third parties, and warned that the finalized enrollment provisions carry few guardrails. In its comments on the proposal, calculated a 7.3-point cumulative market basket shortfall from 2021 to 2025 and joined 18 other organizations in asking for a separate rulemaking. |
| American Hospital Association | In August comments, recommended changes to both the payment and provider enrollment provisions. Its November 4 summary notes that the 2.1% update combines a 3.1% market basket increase with a 1.0% productivity adjustment. |
Technology, legal and policy voices
- Axxess urged CMS to treat interoperable, auditable technology as infrastructure. Its CEO expects data-driven enforcement, including predictive analytics, billing-trend reviews, ownership tracking and utilization comparisons, to flag agencies with inconsistent practices or thin documentation even when no one intended fraud.
- HCHB asked CMS to reconsider the 3% adjustment and to account for staffing, cost and Medicare Advantage pressure.
- Holland & Knight advised hospitals, physician organizations, DMEPOS suppliers and private equity-backed providers to read the rule closely, even if they never touch the home health benefit.
- A physician commenter told CMS that replacing objective fraud criteria with undefined agency discretion could expose primary care and wound care clinicians to revocation, and asked for separate rulemaking.
What the comment record shows
The proposal drew 657 comments, far fewer than the 952,483 filed against last year’s record cut, according to Home Health Care News. A smaller volume of more technical comments suggests the industry has shifted from alarm to argument. The fight now centers on payment methodology, enrollment safeguards and the long recoupment schedule.
Reaction scorecard
| Issue | Mood | Why |
| Aggregate rate increase | Welcomed | First raise after years of cuts and the biggest update in nearly two decades outside 2022, per the Alliance |
| 3% temporary adjustment | Opposed | Seen as detached from true cost, with a long recoupment horizon |
| Retroactive revocation and new grounds | Alarmed | Risk to compliant providers from administrative or third-party errors |
| Palliative care clarification | Welcomed | Gives physicians and agencies confidence to order and build services |
| 45-day OASIS deadline | Low resistance | About 98% of agencies already comply |
| Home health wage index | Supported, unresolved | Request for information only, with no plan |
| Workforce costs | Unresolved | Updates trail those of hospitals and skilled nursing facilities |
How does the 2027 home health rule affect every part of healthcare?
The payment provisions hit home health agencies directly. The enrollment provisions reach every Medicare provider and supplier type. The palliative care, infusion and DMEPOS provisions each open or tighten a specific workflow. Here’s where each care setting feels it.
| Care setting | Main effect | Watch item |
| Home health agencies | Aggregate payment up 2.4%, 3% temporary cut continues, new case-mix weights and LUPA thresholds, 45-day OASIS clock | Cost growth above 2.4% erodes margin |
| Hospice providers | Ownership-change re-enrollment and survey, administrator rules, retroactive revocation | Deal timing and disclosure accuracy |
| Palliative care programs | Skilled palliative care confirmed under the home health benefit | CMS examples still to come |
| Home care and personal care | Indirect: shared labor market and multi-line operator exposure | Whether one revocation touches affiliated lines |
| Hospitals and ambulatory care | Discharge placement depends on agency capacity; enrollment rules apply | Referral acceptance and discharge delays |
| Physician practices | Palliative ordering confidence, managing-employee disclosure, DMEPOS documentation | Revocation grounds |
| Skilled nursing and other post-acute | Retroactive revocation and expanded grounds apply | Owner and managing-employee reporting |
| DMEPOS and home infusion suppliers | Infusion DME coverage from April 1, 2027; no repeat face-to-face for replacements | Ownership-change survey, country-of-origin field |
| Health plans and Medicare Advantage | Indirect, through provider margins and network capacity | MA rates and authorization workflows |
| Health IT, data and compliance teams | 45-day OASIS, audit trails, data-driven enforcement | Patient-level evidence behind every compliance claim |
| Investors and owners | Majority ownership change triggers re-enrollment | Diligence and closing calendars |
| Patients and families | Faster public quality data and clearer palliative access | Rural access and agency exits |
Home health agencies
For home health agencies, the rule sets a rate environment that’s better than 2026 and still tight. The 2.4% aggregate figure is a national estimate. Your result depends on case mix, wage index, LUPA exposure and how fast your costs rise. The recalibrated weights across 432 payment groups, new LUPA thresholds, updated functional levels and comorbidity subgroups all use CY 2025 data, so every agency should re-run its own mix.
- Rebuild the 2027 revenue forecast by case-mix group and model the 3% reduction as its own line.
- Audit OASIS scoring on high-functional-level and high-comorbidity periods, since a scoring error changes payment for the whole 30-day period.
- Move OASIS submission onto a 45-day workflow if you aren’t there already.
- Review every owner and managing employee disclosure before CMS does.
Hospice providers
Hospice providers get no payment update from this rule, because hospice rates move through a separate annual rule. They do face the enrollment package. A change in majority ownership now sends a hospice back through enrollment as a new provider, with a survey or accreditation, and CMS added stricter requirements around administrator qualifications. Retroactive revocation raises the stakes on every disclosure, and the window to submit outstanding claims after a revocation is now 15 days.
The palliative care clarification sits next to hospice, and CMS keeps the two distinct. Hospices that run palliative programs should watch for the sub-regulatory examples. The practical groundwork is governance: named data owners, tested rules and traceable records, which our guide to data governance and CMS compliance frameworks for hospice lays out.
Palliative care programs and physicians
Physicians and program leaders got what they asked for: a statement from CMS that eligible patients with serious illness can receive skilled palliative care, including pain and symptom management, under the home health benefit. HealthView’s CEO said it gives physicians more confidence to order the service, and LiveWell expects to reach seriously ill patients earlier. Commenters such as Dyad Health asked CMS to include caregiver training and a dementia-specific example in the forthcoming guidance.
- Build referral criteria around patient needs and Medicare home health eligibility.
- Define your palliative service line now so you can map it to CMS’s examples when they arrive.
Home care and personal care agencies
Home care agencies outside the Medicare home health benefit still feel this rule. Skilled agencies and home care agencies recruit from the same pool of nurses and aides, so updates that trail those of hospitals keep wage pressure on everyone. Multi-line operators face a second risk: the Alliance warned during the comment period that a revocation can implicate the other provider numbers a company holds. Electronic visit verification and caregiver scheduling remain the compliance basics for this setting.
Hospitals, health systems and ambulatory care
For hospitals and ambulatory networks, the rule matters twice. The enrollment provisions apply to every Medicare provider and supplier type, so hospital and physician group compliance teams need to review disclosure and revocation exposure. The payment provisions shape home health capacity. The Alliance’s comment letter cited data showing 38% of Medicare beneficiaries referred for home health at hospital discharge did not receive it through the third quarter of 2025. If margin pressure leads agencies to tighten admissions, discharge delays can follow.
Physician practices and skilled nursing facilities
The enrollment changes reach physician practices and skilled nursing facilities even though neither bills the home health benefit. Retroactive revocation, the broader license and program suspension grounds and the managing-employee disclosures cover all Medicare provider types. The ownership-change re-enrollment requirement applies only to home health agencies, hospices and DMEPOS suppliers. Practices that order DMEPOS get one piece of relief: an identical replacement item needs no repeat face-to-face visit, as long as the original encounter documentation can be produced on audit.
DMEPOS suppliers and home infusion providers
- Prepare for infusion DME coverage on April 1, 2027, and confirm each drug meets the FDA labeling, qualified supplier and 12-infusions-a-year criteria.
- Treat a majority ownership change as a re-enrollment and survey or accreditation event.
- Keep original face-to-face documentation retrievable for replacement-item audits.
- Collect country-of-origin records for lead items. Suppliers can typically find them in product markings, manufacturer certifications, invoices or customs entry records.
Health plans and Medicare Advantage
The rule governs fee-for-service payment, so health plans aren’t directly bound by it. Plans still watch it, because agencies squeezed on fee-for-service margins have less room to absorb slow authorizations or lower plan rates. LiveWell’s CEO said access depends on both traditional Medicare and Medicare Advantage rates, and HCHB asked CMS to account for plan penetration. MedPAC reported in April that it found no statistically significant effect of Medicare Advantage growth on home health margins, while providers continue to argue their margins are thinner than MedPAC presents. For agencies, authorization status belongs in the revenue forecast, and a prior authorization agent that completes payer forms, submits requests and tracks status can keep it current.
Health IT, data and compliance teams
This is where the rule gets practical. CMS says it will use stronger recovery tools, and observers expect data analytics to drive enforcement. Agencies that can tie every compliance number to a patient-level record answer faster and with less disruption. Our guide to audit-ready dashboards for CMS and compliance reviews shows how to build that trail.
Disclosure accuracy is a data problem as much as a legal one. Owner, managing employee and affiliation records often sit across HR, credentialing, finance and enrollment systems. Data quality, governance and compliance work that reconciles those sources gives compliance officers one version of the truth before a disclosure deadline arrives.
Investors, owners and acquirers
Anyone buying or selling a home health agency, hospice or DMEPOS supplier should treat the ownership-change rule as a deal-timing issue. A qualifying change in majority ownership means re-enrollment as a new provider and a survey or accreditation, with enrollment at risk if the step is missed. The six-month extension of the national enrollment moratorium, announced November 12, still applies to a home health agency that must enroll as a new provider after a qualifying change in majority ownership, so deal calendars carry that constraint too. Holland & Knight flagged private equity-backed providers specifically when the rule was proposed. Diligence now calls for a clean enrollment history, accurate owner and managing employee disclosures under the final definitions, and a realistic re-enrollment calendar.
Patients, families and rural communities
Patients get three tangible changes. Quality data reaches the public up to three months sooner. Skilled palliative care at home gets a clearer path. A steadier base rate may keep more agencies accepting complex referrals. The risk sits in rural areas, where Home Health Care News reports the rule leaves financial pressure only partly addressed, and in any community where enforcement pushes smaller agencies out. HealthView’s CEO expects more providers to exit as enforcement increases.
Will a 2.4% increase cover rising costs?
Only if your costs grow slower than 2.4%. CMS’s figure is a national aggregate, so each agency’s result depends on case mix, wage index, visit patterns and cost growth.
| Your cost growth | Gap versus the 2.4% aggregate | Margin direction |
| 2.4% | 0.0 points | Holds flat |
| 3.5% | -1.1 points | Shrinks |
| 5.0% | -2.6 points | Shrinks fast |
Illustrative arithmetic on CMS’s national aggregate estimate. Actual agency results vary with case mix, wage index and payer mix.
The wider margin debate hasn’t settled. MedPAC’s March 2026 report put freestanding agency margins at 21.2% in 2024, and CMS maintains that payments exceed costs. In comments on the proposal, MedPAC also supported the temporary adjustment and said the base rate exceeds the estimated cost of a typical 30-day period by 34%. LeadingAge, citing CMS Office of the Actuary data, says 36% of agencies had negative total all-payer margins that year. The Alliance says permanent PDGM reductions have already cut the 30-day rate by 9.37%. Both camps can be right because they measure different things: Medicare-only margins on one side, all-payer margins on the other, and averages that hide a wide spread.
Labor drives most of the gap. VNS Health’s Savitt says the 5.8% cumulative update since 2020 leaves agencies unable to compete with hospitals for nurses and therapists. Agencies can’t change the rate, so many are working on the number they control: visit capacity. Our piece on home health staffing analytics and capacity planning covers turnover, scheduling friction, drive time and documentation load.
What should healthcare leaders do in the next 90 days?
Start with two documents: a 2027 revenue forecast built by case-mix group, and an inventory of every owner, managing employee and affiliation CMS could ask about. Then assign each role an owner.
| Role | Priority actions |
| CEO and board | Name an owner for the 2027 enforcement-readiness plan. Check ownership and transaction calendars against the re-enrollment rule. Set a margin trigger that tells you when admissions policy needs review. |
| CFO and revenue cycle | Rebuild the forecast by case-mix group. Model the 3% reduction as a switch. Stress-test cost growth at 3.5% and 5%. Track Medicare Advantage authorization status. |
| Compliance and enrollment | Inventory owners, managing employees (including clinical leadership titles) and affiliations. Test disclosure timelines. Document the facts and circumstances behind any past issue. Prepare for contractor requests. |
| Clinical and quality | Move OASIS submission to a 45-day workflow. Audit functional scoring. Map palliative referral criteria. Prepare for CMS examples. |
| IT and data | Build patient-level audit trails. Unify owner, clinician and billing records. Stand up dashboards for compliance KPIs. |
Where AI fits deserves a precise answer. No tool changes the CMS rate or replaces clinical judgment. Inferenz’s healthcare pages describe Caregence agents built for specific jobs in each setting, including OASIS accuracy and documentation monitoring for home health, HOPE compliance monitoring for hospice, and EVV compliance monitoring for home care. Those jobs sit in the places where this rule raises the cost of error. The full set is on the Caregence agents page.
What happens next after the home health final rule?
| Date | Milestone |
| November 4, 2026 | CMS issues the final rule and places it on public display |
| November 9, 2026 | Rule published in the Federal Register (91 FR 72022) |
| November 12, 2026 | CMS extends the national home health and hospice enrollment moratoria by six months |
| Early January 2027 | Expected effective date for the enrollment provisions, about 60 days after the November 4 filing (the Federal Register date line needs confirming) |
| After publication | CMS guidance with examples of skilled palliative care (no date announced) |
| January 1, 2027 | Calendar year 2027 begins; 2027 rates and policies apply, and the new OASIS deadline takes effect with the CY 2027 reporting program year |
| April 1, 2027 | Home infusion DME expansion takes effect |
| Summer 2027 (typical timing) | CY 2028 proposed rule expected; CMS’s CY 2026 claims analysis may bring permanent adjustments back to the table |
| Ongoing | Watch for CMS decisions on the home health and hospice moratoria, which the six-month extension carries to mid-May 2027 |
Final thoughts
Rate relief and tighter enforcement arrived together, and agencies will feel both. The raise gives leaders a steadier baseline for the first time in years. The enrollment provisions favor organizations whose records are clean, current and traceable. The rule text will keep getting parsed over the coming weeks, and CMS guidance on palliative care is still to come. Start with the forecast and the disclosure inventory. Everything else follows from those two.

















